Kazuya Sakai¹, Hideo Yagi¹, Masaki Hayakawa¹, Kaori Harada², Tatsuhiko Someya², Yoshihiro Fujimura³, Masanori Matsumoto¹ (1.Department of Blood Transfusion Medicine, Nara Medical University, Nara, Japan, 2.TAGCyx Biotechnologies Inc, Tokyo, Japan, 3.Japanese Red Cross Kinki Brock Blood Center, Osaka, Japan)

Akihiro Otsu¹, Shugo Kowata¹, Ryo Togawa¹, Tadashi Shimoyama¹, Maki Nishiya¹, Norifumi Sugawara¹, Ryousei Sasaki¹, Wataru Izumita¹, Satsuki Kamihara¹, Yasuhiko Tsukushi¹, Tatsuo Oyake¹, Kazunori Murai², Yoji Ishida¹, Takashi Ishida¹ (1.Hematol., Iwate Med Univ., Iwate, Japan, 2.Hematol., Iwate Prefectural Central Hospital, Iwate, Japan)

Yukako Ono-Uruga¹, Masaki Yazawa², Keiichi Tozawa³, Taisuke Mori⁴, Yasuo Ikeda⁵, Yumiko Matsubara^1,6 (1.Clinical and Translational Research Center, Keio University, Tokyo, Japan., 2.Department of Plastic and Reconstructive Surgery, Keio University, Tokyo, Japan., 3.Division of Hematology, Keio University, Tokyo, Japan., 4.Department of Pathology, National Cancer Center Hospital, Tokyo, Japan., 5.Life Science and Medical Bioscience, Waseda University, Tokyo, Japan., 6.Department of Laboratory Medicine, Keio University, Tokyo, Japan)

Yumi Ogura¹, Makiko Mori², Katsuyoshi Koh², Hiroshi Yoshino³, Noritaka Niyazawa³, Masatoshi Tokita³, Chihaya Imai⁴, Yohichiro Hirata⁵, Ryo Inuduka⁵, Shinji Kunishima⁶, Shigeaki Nonoyama¹, Hiroyuki Kawaguchi¹ (1.Pediatr., National Defense Medical College, Saitama, Japan, 2.Department of Hematology-Oncology, Saitama Children's Medical Center, Saitama, 3.Department of Pediatrics, Kyorin University, Tokyo, 4.Department of Homeostatic Regulation and Development, Niigata University, Niigata, 5.Department of Pediatrics, University of Tokyo, Japan, 6.Clinical Research Center, Nagoya Medical Center, Nagoya)

Keigo Akuta¹, Kazunobu Kiyomizu¹, Hirokazu Kashiwagi¹, Shinji Kunishima², Fumiaki Banno³, Koichi Kokame³, Nobuko Nishiura¹, Yoichiro Morikawa¹, Hisashi Kato¹, Shigenori Honda³, Yuzuru Kanakura¹, Toshiyuki Miyata⁴, Yoshiaki Tomiyama⁵ (1.Department of Hematology and Oncology, Osaka University, Suita, Japan, 2.Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 3.Department of Molecular Pathogenesis, National Cerebral Cardiovascular Center, Suita, Japan, 4.Department of Cerebrovascular Medicine, National Cerebral Cardiovascular Center, Suita, Japan, 5.Department of Blood Transfusion, Osaka University Hospital, Suita, Japan)

Sou Nakamura¹, Yukitaka Ito^1,2, Naoshi Sugimoto^1,3, Yoshikazu Kato⁴, Shinya Sakuma⁵, Keitaro Ito⁵, Hiroki Kumon⁵, Mikiko Ohno⁶, Eiichiro Nishi⁶, Fumihito Arai⁵, Satoshi Nishimura⁷, Koji Eto^1,8 (1.Center for iPS Cell Research and Application, Kyoto University, Kyoto., 2.Kyoto Development Center, Megakaryon Corporation, Kyoto., 3.Department of Hematology, Kagawa University Hospital, Kagawa., 4.Mixing Technology Laboratory, SATAKE Chemical Equipment MFG. LTD., 5.Department of Micro-Nano Systems Engineering, Nagoya University, Nagoya., 6.Department of Pharmacology, Shiga University of Medical Science, Otsu., 7.Center for Molecular Medicine, Jichi Medical University, Tochigi., 8.Department of Regenerative Medicine, Chiba University, Chiba.)